Here's the live share price of Suraksha Diagnostic along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Suraksha Diagnostic has declined 7.61% CAGR. Over the past year, the corresponding return has been -32.70%.
Suraksha Diagnostic’s current P/E of 45.89x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Suraksha Diagnostic | -3.05 | -13.41 | -7.19 | -15.3 | -32.7 | -12.36 | -7.61 |
| Max Healthcare Institute | -6.76 | -4.82 | -6.78 | -5.67 | 1.73 | 35.27 | 50.72 |
| Apollo Hospitals Enterprise | -1.9 | -8.02 | -9.05 | 4.81 | -0.66 | 14.58 | 24.17 |
| Fortis Healthcare | -3.9 | -13.02 | -6.74 | 19.96 | 24.63 | 45.44 | 44.19 |
| Narayana Hrudayalaya | -0.91 | 5.69 | 5.33 | 11.24 | 46.98 | 36.68 | 38.69 |
| Aster DM Healthcare | -1.58 | -4.65 | 3.25 | 12.66 | 35.43 | 41.61 | 31.67 |
| Global Health | -4.28 | -3.92 | -15.44 | 0.26 | 3.32 | 38.01 | 23.62 |
| Krishna Institute of Medical Sciences | 3.1 | -1.71 | -4.7 | 5.52 | 15.83 | 32.75 | 28.76 |
| Dr. Lal Pathlabs | -2.71 | -3.84 | -8.86 | 6.46 | 2.05 | 6.79 | 6.28 |
| Dr. Agarwals Health Care | -4.42 | -2.49 | 20.22 | 45.16 | 25.04 | 7.73 | 4.57 |
| Rainbow Childrens Medicare | -0.84 | -3.15 | -11.39 | -3.3 | -19.62 | 21.47 | 24.5 |
| Vijaya Diagnostic Centre | 6.9 | 5.24 | -0.9 | 11.93 | -5.21 | 32.59 | 11.74 |
| Healthcare Global Enterprises | 0.59 | -6.23 | 3.14 | 29.94 | 42.91 | 32.85 | 37.3 |
| Metropolis Healthcare | -0.54 | -5.36 | -13.98 | 13.56 | -8.55 | 9.78 | -0.74 |
| Jupiter Life Line Hospitals | -0.82 | -6.64 | 0.35 | -1.02 | -4.3 | 10.43 | 6.13 |
| Thyrocare Technologies | -13.17 | -5.75 | -4.51 | 27.7 | 25.5 | 25.92 | 4.05 |
| Yatharth Hospital & Trauma Care Services | -11.2 | -16.66 | -11.02 | 34.93 | 10.91 | 27.06 | 15.45 |
| Kovai Medical Center and Hospital | -0.58 | -2.88 | -4.47 | -3.95 | 8.44 | 50.47 | 39.67 |
| Indraprastha Medical Corporation | -4.04 | -18.62 | 0.88 | 12.6 | -2.6 | 79.37 | 55.8 |
| Artemis Medicare Services | -6.2 | 9.54 | 18.38 | -1.4 | -20.66 | 51.89 | 69.13 |
Over the last one year, Suraksha Diagnostic has declined 32.70% compared to peers like Max Healthcare Institute (1.73%), Apollo Hospitals Enterprise (-0.66%), Fortis Healthcare (24.63%). From a 5 year perspective, Suraksha Diagnostic has underperformed peers relative to Max Healthcare Institute (50.72%) and Apollo Hospitals Enterprise (24.17%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 291.58 | 286.22 |
| 10 | 296.24 | 291.25 |
| 20 | 305.69 | 297.57 |
| 50 | 305.73 | 303.47 |
| 100 | 307.19 | 307.44 |
| 200 | 305.43 | 313.25 |
In the latest quarter, Suraksha Diagnostic saw a rise in promoter holding to 48.99%, while DII stake decreased to 21.98%, FII holding fell to 13.73%, and public shareholding moved up to 15.30% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 38,96,349 | 1.48 | 123.88 | |
| 30,43,015 | 0.54 | 96.75 | |
| 16,39,777 | 0.33 | 52.14 | |
| 3,34,736 | 1.26 | 10.64 | |
| 2,46,930 | 0.34 | 7.85 | |
| 2,40,314 | 0.75 | 7.64 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Dec 02, 2025, 8:59 PM IST | Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Nov 14, 2025, 8:53 PM IST | Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 11, 2025, 10:41 PM IST | Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 10, 2025, 11:25 PM IST | Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 10, 2025, 10:40 PM IST | Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Investor Presentation |
Suraksha Diagnostic Ltd. is a Public Limited Listed company incorporated on 15/03/2005 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is U85110WB2005PLC102265 and registration number is 102265. Currently company belongs to the Industry of Hospitals & Medical Services. Company's Total Operating Revenue is Rs. 249.10 Cr. and Equity Capital is Rs. 10.42 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Suraksha Diagnostic is ₹281.30 as on Dec 04, 2025.
The Suraksha Diagnostic is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Suraksha Diagnostic is ₹1,465.03 Cr as on Dec 04, 2025.
Today’s highest and lowest price of Suraksha Diagnostic are ₹281.85 and ₹273.00.
The 52-week high/low is the highest and lowest price at which Suraksha Diagnostic stock has traded in the past 52-week or nearly a year. The 52-week high of Suraksha Diagnostic is ₹449.00 and 52-week low of Suraksha Diagnostic is ₹231.00 as on Dec 04, 2025.
The Suraksha Diagnostic has shown returns of 0.59% over the past day, -13.41% for the past month, -7.19% over 3 months, -32.7% over 1 year, -12.36% across 3 years, and -7.61% over 5 years.
P/E ratio of and PB ratio of Suraksha Diagnostic are 45.89 and 6.94 on Dec 04, 2025. While the company gives a dividend yield of 0.00 per annum.